Broderick Brian C lowered its position in shares of Cigna Corporation (NYSE:CI) by 8.3% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,495 shares of the health services provider’s stock after selling 405 shares during the period. Broderick Brian C’s holdings in Cigna Corporation were worth $752,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Guardian Life Insurance Co. of America raised its position in shares of Cigna Corporation by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 990 shares of the health services provider’s stock valued at $145,000 after buying an additional 7 shares during the last quarter. Bronfman E.L. Rothschild L.P. raised its stake in shares of Cigna Corporation by 1.1% in the first quarter. Bronfman E.L. Rothschild L.P. now owns 2,112 shares of the health services provider’s stock valued at $309,000 after buying an additional 22 shares in the last quarter. Boys Arnold & Co. Inc. raised its stake in shares of Cigna Corporation by 1.8% in the first quarter. Boys Arnold & Co. Inc. now owns 1,833 shares of the health services provider’s stock valued at $269,000 after buying an additional 33 shares in the last quarter. Winslow Evans & Crocker Inc. raised its stake in shares of Cigna Corporation by 1.9% in the second quarter. Winslow Evans & Crocker Inc. now owns 1,814 shares of the health services provider’s stock valued at $304,000 after buying an additional 34 shares in the last quarter. Finally, IFP Advisors Inc raised its stake in shares of Cigna Corporation by 1.9% in the first quarter. IFP Advisors Inc now owns 2,180 shares of the health services provider’s stock valued at $319,000 after buying an additional 41 shares in the last quarter. 86.91% of the stock is owned by institutional investors and hedge funds.
Shares of Cigna Corporation (NYSE:CI) opened at 175.36 on Friday. Cigna Corporation has a 1-year low of $115.03 and a 1-year high of $178.57. The stock has a market capitalization of $44.15 billion, a PE ratio of 20.23 and a beta of 0.46. The stock has a 50 day moving average price of $172.11 and a 200-day moving average price of $158.96.
Cigna Corporation (NYSE:CI) last released its quarterly earnings results on Friday, August 4th. The health services provider reported $2.91 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.48 by $0.43. Cigna Corporation had a return on equity of 17.40% and a net margin of 7.46%. The firm had revenue of $10.32 billion for the quarter, compared to analyst estimates of $10.26 billion. During the same quarter last year, the company posted $1.98 earnings per share. The business’s revenue was up 3.6% on a year-over-year basis. On average, analysts forecast that Cigna Corporation will post $10.02 earnings per share for the current year.
COPYRIGHT VIOLATION WARNING: This article was originally posted by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this article on another publication, it was copied illegally and republished in violation of United States and international copyright legislation. The original version of this article can be read at https://stocknewstimes.com/2017/08/11/broderick-brian-c-lowers-position-in-cigna-corporation-ci-updated-updated.html.
Several analysts have issued reports on the company. UBS AG reaffirmed a “buy” rating and issued a $186.00 target price (up previously from $181.00) on shares of Cigna Corporation in a research note on Monday, June 5th. Deutsche Bank AG upped their target price on Cigna Corporation from $180.00 to $190.00 and gave the stock a “buy” rating in a research note on Monday. Royal Bank Of Canada reiterated a “buy” rating and issued a $185.00 price objective on shares of Cigna Corporation in a research report on Wednesday. BidaskClub downgraded Cigna Corporation from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 31st. Finally, Citigroup Inc. boosted their price objective on Cigna Corporation from $185.00 to $198.00 and gave the company a “buy” rating in a research report on Monday. Three analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the stock. Cigna Corporation has a consensus rating of “Buy” and a consensus target price of $180.06.
In other Cigna Corporation news, EVP Nicole S. Jones sold 20,312 shares of Cigna Corporation stock in a transaction that occurred on Wednesday, May 17th. The stock was sold at an average price of $160.04, for a total value of $3,250,732.48. Following the sale, the executive vice president now owns 44,737 shares of the company’s stock, valued at approximately $7,159,709.48. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Michael W. Triplett sold 3,700 shares of Cigna Corporation stock in a transaction that occurred on Tuesday, August 8th. The shares were sold at an average price of $174.96, for a total value of $647,352.00. Following the completion of the sale, the insider now directly owns 21,060 shares in the company, valued at approximately $3,684,657.60. The disclosure for this sale can be found here. In the last three months, insiders have sold 261,014 shares of company stock worth $44,434,114. Corporate insiders own 1.30% of the company’s stock.
About Cigna Corporation
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.
